Efficacy and safety of ivermectin versus high dose albendazole for chronic strongyloidiasis in immunocompromised patients

✍ Scribed by Y. Suputtamongkol; K. Bhumimuang; D. Waywa; S. Nilganuwong; N. Premasathian; A. Karuphong; T. Anekthananon; D. Wanachiwanawin; S. Silpasakorn

• Book ID: 118451540
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 80 KB
• Volume: 14
• Category: Article
• ISSN: 1201-9712
• DOI: 10.1016/j.ijid.2010.02.2137